The most prevalent retinal diseases include dry and wet age-related macular degeneration, diabetic macular oedema, diabetic retinopathy, retinal vein occlusion, cystoid macular oedema and uveitis. Some of these conditions are chronic or recurring and can present as early as age 40.
Oxular’s development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema and aged related macular degeneration, plus programs for rare and orphan conditions, including ocular cancers and delivery of gene therapy.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.